EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses
about
Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients.Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.A predictive model for corticosteroid response in individual patients with MS relapsesA tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing-remitting multiple sclerosis subjects.Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.A proposed roadmap for inpatient neurology quality indicatorsPatient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.Clinical evaluation of natalizumab for formulary consideration.Disease-specific therapy of idiopathic inflammatory demyelinating disorders.Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study.A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.Outcome of MS relapses in the era of disease-modifying therapy.Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines.Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy.Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis.High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS): a pilot study.Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.GSH-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.Therapeutic plasma exchange combined with immunomodulating agents in secondary progressive multiple sclerosis patients.Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.B-cell subsets: cellular interactions and relevance in multiple sclerosis
P2860
Q30672336-2B7DA227-CC9A-4CD1-BA94-3E2A04E7C5FCQ33921755-CAD08C16-961A-4F18-9EAA-E60DE405404EQ34296297-D65F27A1-146B-4D9D-B557-7B3DCB47BF97Q35192482-BBA84E8B-7B4F-4A8C-AC47-5654D8A054BAQ35305266-17C7B796-C9ED-441D-B84A-EAB886637B76Q35476281-0F3D61BE-9FD6-41E6-A6C9-4E05C054F6F9Q35731510-DD866C2B-80D0-47EB-A9BC-8C361D3256D7Q35811145-C84211E3-56F6-4DF7-A1C0-3BCDDE835D96Q35921568-20297E20-51A9-486F-A78F-ABDCA5AD0D17Q36492655-E1ED21FE-521E-4BF4-9B76-6949B4029DF2Q36915999-AB75FADD-A3EF-458E-8AE8-2B90D8757591Q37052740-F9BA6F70-5B9F-4F4A-9BD7-2E3E31FAAB71Q37146935-BC3E1C0B-EB27-45ED-8E34-096FBF3DC9C5Q37442240-A0D40033-6B44-4913-8A31-F8EA347D07E5Q37599583-55AFE627-ADCE-485D-BB17-32830BC14162Q37772171-CDC586A9-7693-4540-A6EB-FF38DB8F28FBQ38049628-8C8D8D0C-4BA1-4E96-9778-CCE54C66776BQ38415327-3FE180F1-64DD-4842-92BB-BD7709DCF79FQ38442625-61EA5DAC-E0D1-41C7-B4DB-B1B6CC7EE5ACQ38636590-6521D647-2134-4DA5-9068-5A95E00E0F47Q38749019-8D8E2220-DDD3-47DD-A4AC-A277FA5EC899Q39967971-11603911-AB71-44A6-B315-69B1B8A8BFA6Q41057804-F3EF0781-B7BA-45CB-B564-5FF651EC5D33Q41522083-C857C902-9346-40AB-9D99-23C39F170FCBQ42253020-4769C0C4-9A63-4627-9745-106C22E950F0Q45998750-18E16B2E-9B95-4811-8180-2EB409222114Q46609780-BD470561-4E27-444F-B0D2-B44F43BA8750Q47547802-C83ECD19-5DF8-458C-AB28-47A5051B4D39Q47678330-5760CEA9-C528-4731-8281-40E49F522870Q51708003-C434DAD2-39B7-4CA1-AD50-6070390163B4Q55283252-0997BCF5-1528-479C-856E-BCFC7B9788FBQ57041869-C961FD16-27FB-407B-9549-7450D1D9AA27
P2860
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@ast
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@en
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@nl
type
label
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@ast
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@en
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@nl
prefLabel
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@ast
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@en
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@nl
P2093
P2860
P3181
P1476
EFNS guideline on treatment of ...... of multiple sclerosis relapses
@en
P2093
F Sellebjerg
G Filippini
L H Visser
P Rieckmann
X Montalban
P2860
P304
P3181
P356
10.1111/J.1468-1331.2005.01352.X
P407
P577
2005-12-01T00:00:00Z